11 Nov
2021

Moderna on IP collision course with US government

On top of existing IP sharing controversies, Moderna now finds itself at loggerheads with the US federal government over inventorship of crucial vaccine technology.

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth